Bilaketaren emaitzak - Angela Sinn

  • Erakusten 1 - 1 emaitzak -- 1
Findu emaitzak
  1. 1
    Azala

    Remibrutinib (LOU064): A selective potent oral BTK inhibitor with promising clinical safety and pharmacodynamics in a randomized phase I trial nork Martin Kaul, Peter End, Maciej Cabanski, Carole Schuhler, Annamaria Jakab, Magdalena Kistowska, Arvind Kinhikar, Alessio Maiolica, Angela Sinn, Rainard Fuhr, Bruno Cenni

    Argitaratua 2021
    Connect to this object online.
    Liburua

    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: